High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study

We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitione...

Full description

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 172; no. 1; pp. 95 - 105
Main Authors Diehm, Curt, Schuster, Alexander, Allenberg, Jens R., Darius, Harald, Haberl, Roman, Lange, Stefan, Pittrow, David, von Stritzky, Berndt, Tepohl, Gerhart, Trampisch, Hans-Joachim
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ireland Ltd 2004
Elsevier
Subjects
Online AccessGet full text
ISSN0021-9150
DOI10.1016/S0021-9150(03)00204-1

Cover

Abstract We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m 2, mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD.
AbstractList We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m(2), mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD.
We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m(2), mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD.We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m(2), mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD.
We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of the observational German Epidemiological Trial on Ankle Brachial Index (getABI study), 344 general practitioners throughout Germany determined the ABI of consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. Additional assessments comprised patient history with the focus on atherothrombotic diseases, physical examination, and the WHO questionnaire on intermittent claudication. A total of 6880 patients were included (42.0% male, mean age 72.5 years, mean body mass index 27.3 kg/m 2, mean systolic/diastolic blood pressure 143.7/81.3 mmHg). The prevalence of PAD for men/women as indicated by an ankle brachial index (AB1)<0.9 was 19.8/16.8%. Patients with PAD were slightly older than patients without PAD, suffered more frequently from diabetes (36.6 vs. 22.6%; adjusted OR: 1.8), hypertension (78.8 vs. 61.6%; OR: 2.2), lipid disorders (57.2 vs. 50.7%; OR: 1.3) and other coexisting atherothrombotic diseases (any cerebrovascular event: 15.0 vs. 7.6%; OR: 1.8; any cardiovascular event: 28.9 vs. 17.0%; OR: 1.5). The data highlight the high prevalence of PAD in primary care. PAD patients are characterised by a high co-morbidity, particularly with regard to other manifestations of atherothrombosis. Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD.
Author Schuster, Alexander
Diehm, Curt
Allenberg, Jens R.
Tepohl, Gerhart
Trampisch, Hans-Joachim
von Stritzky, Berndt
Darius, Harald
Lange, Stefan
Pittrow, David
Haberl, Roman
Author_xml – sequence: 1
  givenname: Curt
  surname: Diehm
  fullname: Diehm, Curt
  email: curt.diehm@kkl.srh.de
  organization: Department of Internal Medicine, Vascular Medicine, Affiliated Teaching Hospital, University of Heidelberg, Guttmannstr. 1, D-76307 Karlsbad, Germany
– sequence: 2
  givenname: Alexander
  surname: Schuster
  fullname: Schuster, Alexander
  organization: 3P Consulting, D-82393 Pöcking, Germany
– sequence: 3
  givenname: Jens R.
  surname: Allenberg
  fullname: Allenberg, Jens R.
  organization: Department of Vascular Surgery, Section for Vascular Surgery, Ruprecht-Karls University of Heidelberg, D-69120 Heidelberg, Germany
– sequence: 4
  givenname: Harald
  surname: Darius
  fullname: Darius, Harald
  organization: Department of Medicine, Klinikum Berlin-Neukölln, Vivantes Netzwerk für Gesundheit, D-12313 Berlin, Germany
– sequence: 5
  givenname: Roman
  surname: Haberl
  fullname: Haberl, Roman
  organization: Department of Neurology, Städtisches Krankenhaus München-Harlaching, D-81545 Munich, Germany
– sequence: 6
  givenname: Stefan
  surname: Lange
  fullname: Lange, Stefan
  organization: Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, D-44780 Bochum, Germany
– sequence: 7
  givenname: David
  surname: Pittrow
  fullname: Pittrow, David
  organization: Department of Clinical Pharmacology, Medical Faculty, Technical University of Dresden, D-01307 Dresden, Germany
– sequence: 8
  givenname: Berndt
  surname: von Stritzky
  fullname: von Stritzky, Berndt
  organization: Medical Department, Sanofi-Synthelabo, D-10785 Berlin, Germany
– sequence: 9
  givenname: Gerhart
  surname: Tepohl
  fullname: Tepohl, Gerhart
  organization: Practice for Vascular Medicine, D-80336 Munich, Germany
– sequence: 10
  givenname: Hans-Joachim
  surname: Trampisch
  fullname: Trampisch, Hans-Joachim
  organization: Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, D-44780 Bochum, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15383525$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/14709362$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtv1TAQhb0oog_4CSBvQLAIjOM4cUAIoQooUiUWwNpy7AkdyHVS27fS_ff4PqBSN2Vh2WN950hzzik7CnNAxp4IeCVAtK-_AdSi6oWCFyBflgGaShyxk3_fx-w0pV8A0HRCP2THoumgl219wvIF_bziS8QbO2FwyOeRLxhpucJoJ25jLkN5eEpoE3IbPHdztZrjQJ7yhlPgrdZQLGhl44Y7G5EvNhOGnN5wF-eUqoQu0xyKT8prv3nEHox2Svj4cJ-xH58-fj-_qC6_fv5y_uGyckqIXHVet4Ps3SDAjiDrXksA34tyagFoXaMH1dbYKT0iyk6qseuHtpd9J1xjR3nGnu99lzhfrzFls6LkcJpswHmdjAbQstVNAZ8ewPWwQm8Oy5i_ORXg2QGwydlpjDY4SrecklqqWhVO7bnd3hHHWwTMtiuz68psSzEgza4rI4ru7R2do2y3meVoabpX_X6vxhLmDWE0ydG2TU-xJG_8TPc6vLvj4CYKVFb9jZv_0P8BK2nBtw
CitedBy_id crossref_primary_10_1111_j_1538_7836_2006_02225_x
crossref_primary_10_2214_AJR_19_21520
crossref_primary_10_1007_s10389_018_0898_4
crossref_primary_10_1038_nrrheum_2012_16
crossref_primary_10_3109_08037051_2010_491178
crossref_primary_10_1191_1358863x05vm591xx
crossref_primary_10_1016_j_jpain_2008_09_001
crossref_primary_10_1016_S2255_4823_12_70248_5
crossref_primary_10_1007_s00103_017_2676_9
crossref_primary_10_1038_hr_2012_83
crossref_primary_10_1253_circj_71_95
crossref_primary_10_1016_j_jacc_2017_03_024
crossref_primary_10_5758_kjves_2011_27_4_168
crossref_primary_10_1007_s00772_005_0409_0
crossref_primary_10_1007_s12602_023_10191_2
crossref_primary_10_1016_j_angio_2013_01_012
crossref_primary_10_1016_j_mri_2022_08_001
crossref_primary_10_1583_04_1449_1
crossref_primary_10_1016_j_apmr_2005_11_025
crossref_primary_10_2169_internalmedicine_49_3884
crossref_primary_10_1016_j_jvs_2009_08_085
crossref_primary_10_1111_j_1600_0404_2006_00725_x
crossref_primary_10_1016_S0304_5412_09_73019_7
crossref_primary_10_1111_j_1747_4949_2010_00440_x
crossref_primary_10_1007_s12055_013_0246_9
crossref_primary_10_1111_all_12354
crossref_primary_10_1007_s00772_013_1178_9
crossref_primary_10_1002_jmri_23944
crossref_primary_10_2337_dc08_1639
crossref_primary_10_1016_j_ejrad_2012_12_021
crossref_primary_10_1007_s00330_012_2625_9
crossref_primary_10_1136_bmjopen_2021_057630
crossref_primary_10_1093_eurheartj_eht288
crossref_primary_10_1016_j_yasu_2009_02_002
crossref_primary_10_1016_j_atherosclerosis_2008_05_046
crossref_primary_10_15656_kjcg_2022_23_1_9
crossref_primary_10_1007_s10856_015_5506_3
crossref_primary_10_1016_j_jdiacomp_2007_06_011
crossref_primary_10_1016_j_pain_2006_04_011
crossref_primary_10_3390_jcm12134411
crossref_primary_10_3390_ijms231810481
crossref_primary_10_1007_s00117_009_1911_2
crossref_primary_10_1007_s00772_012_1109_1
crossref_primary_10_1007_s00772_020_00736_y
crossref_primary_10_1007_s00772_021_00786_w
crossref_primary_10_1007_s00115_007_2305_1
crossref_primary_10_1136_bmjopen_2021_054352
crossref_primary_10_1007_s11428_008_0338_0
crossref_primary_10_1038_jhh_2013_99
crossref_primary_10_1007_s15006_018_0002_6
crossref_primary_10_4078_jrd_2012_19_1_63
crossref_primary_10_1002_ccd_21401
crossref_primary_10_1007_s00270_017_1674_5
crossref_primary_10_1016_j_ejvs_2009_11_007
crossref_primary_10_3390_jcm11082155
crossref_primary_10_1016_j_jstrokecerebrovasdis_2011_08_011
crossref_primary_10_1177_15266028060130S205
crossref_primary_10_1161_CIR_0b013e31822e80c3
crossref_primary_10_1002_jmri_21540
crossref_primary_10_1111_iwj_12003
crossref_primary_10_1002_14651858_CD001368_pub4
crossref_primary_10_1371_journal_pone_0167408
crossref_primary_10_1016_j_acvfr_2011_11_012
crossref_primary_10_1055_a_1771_0056
crossref_primary_10_1186_1745_6215_13_215
crossref_primary_10_1016_j_ejvs_2011_08_014
crossref_primary_10_1177_1526602819849955
crossref_primary_10_1016_j_ccl_2005_03_006
crossref_primary_10_1097_SLA_0000000000006375
crossref_primary_10_1016_j_angio_2015_04_013
crossref_primary_10_1185_03007990903223895
crossref_primary_10_3238_arztebl_2020_0188
crossref_primary_10_1007_s00547_005_2055_5
crossref_primary_10_1186_s13293_022_00432_4
crossref_primary_10_1007_s00772_022_00922_0
crossref_primary_10_1016_j_atherosclerosis_2010_11_030
crossref_primary_10_1016_j_atherosclerosis_2021_09_022
crossref_primary_10_1016_j_jcin_2013_10_004
crossref_primary_10_1007_s00772_010_0784_z
crossref_primary_10_1007_s00108_011_2814_7
crossref_primary_10_1016_j_acvfr_2011_11_020
crossref_primary_10_1016_j_avsg_2021_07_057
crossref_primary_10_1016_j_atherosclerosis_2022_10_002
crossref_primary_10_1111_j_1742_1241_2010_02337_x
crossref_primary_10_1007_s00392_005_1406_8
crossref_primary_10_1007_BF03324882
crossref_primary_10_1016_j_avsg_2021_06_011
crossref_primary_10_1016_j_ejvs_2008_01_013
crossref_primary_10_1007_s00772_009_0693_1
crossref_primary_10_1016_j_ijge_2018_02_001
crossref_primary_10_1016_j_jvs_2007_11_056
crossref_primary_10_1007_BF03324767
crossref_primary_10_1007_s00270_007_9095_5
crossref_primary_10_1007_s13244_012_0180_1
crossref_primary_10_1016_j_ejvs_2005_11_022
crossref_primary_10_1177_0003319716677667
crossref_primary_10_1016_j_avsg_2015_11_009
crossref_primary_10_1093_eurheartj_ehac016
crossref_primary_10_2217_WHE_09_60
crossref_primary_10_1055_a_1679_6334
crossref_primary_10_1016_j_ejvs_2009_12_003
crossref_primary_10_1080_17446651_2016_1175936
crossref_primary_10_1016_j_athoracsur_2024_01_021
crossref_primary_10_1016_j_jvs_2020_06_104
crossref_primary_10_1016_j_jvs_2008_07_062
crossref_primary_10_1016_j_cpcardiol_2012_07_001
crossref_primary_10_23736_S0026_4806_22_07909_5
crossref_primary_10_1177_1358863X19883945
crossref_primary_10_1016_S0304_5412_09_73017_3
crossref_primary_10_23736_S0392_9590_19_04167_1
crossref_primary_10_1139_y2012_010
crossref_primary_10_1016_j_ehj_2018_06_005
crossref_primary_10_1016_j_jtumed_2016_01_010
crossref_primary_10_1016_j_ejvs_2013_04_006
crossref_primary_10_1007_s10389_008_0223_8
crossref_primary_10_1016_j_jvs_2009_08_051
crossref_primary_10_1007_s11095_005_6334_9
crossref_primary_10_1007_s00115_014_4125_4
crossref_primary_10_1007_s12181_021_00520_6
crossref_primary_10_1186_s12955_014_0171_7
crossref_primary_10_1002_jmri_21351
crossref_primary_10_1016_S1134_2072_09_71418_5
crossref_primary_10_1097_HJR_0b013e32831c1383
crossref_primary_10_1016_j_avsg_2022_02_009
crossref_primary_10_1007_s11428_008_0336_2
crossref_primary_10_7251_bii1902128l
crossref_primary_10_1007_s00330_009_1607_z
crossref_primary_10_1016_j_jvs_2006_02_019
crossref_primary_10_1177_1708538112472288
crossref_primary_10_12687_phleb2318_4_2016
crossref_primary_10_5339_gcsp_2013_13
crossref_primary_10_1055_a_1916_9717
crossref_primary_10_1177_1358863X15616687
crossref_primary_10_1007_s12181_012_0453_4
crossref_primary_10_1186_s12872_022_02751_1
crossref_primary_10_1007_s12055_015_0415_0
crossref_primary_10_1016_j_atherosclerosis_2021_03_019
crossref_primary_10_1186_1756_0500_6_404
crossref_primary_10_1177_0003319709348295
crossref_primary_10_1177_2048004020907002
crossref_primary_10_1016_j_jvs_2005_01_047
crossref_primary_10_1177_1358863X13483864
crossref_primary_10_1007_s00104_007_1367_8
crossref_primary_10_1111_j_1747_4949_2011_00752_x
crossref_primary_10_1161_01_HYP_0000196686_85286_9c
crossref_primary_10_1161_JAHA_122_026347
crossref_primary_10_1177_1359105315600238
crossref_primary_10_1157_13086042
crossref_primary_10_1007_s11739_011_0511_0
crossref_primary_10_3238_arztebl_2016_0729
crossref_primary_10_1024_0301_1526_a000700
crossref_primary_10_1016_j_jvs_2009_01_004
crossref_primary_10_1093_eurjcn_zvad044
crossref_primary_10_3238_arztebl_m2024_0008
crossref_primary_10_1007_s00270_005_0296_5
crossref_primary_10_1016_j_atherosclerosis_2004_02_001
crossref_primary_10_3238_arztebl_2008_0769
crossref_primary_10_1007_s12262_011_0364_9
crossref_primary_10_1007_s00415_007_0590_z
crossref_primary_10_1016_j_avsg_2014_09_003
crossref_primary_10_1016_j_atherosclerosis_2004_02_002
crossref_primary_10_1007_s11739_012_0854_1
crossref_primary_10_1016_j_surge_2011_05_003
crossref_primary_10_1007_s00108_009_2365_3
crossref_primary_10_1007_s00270_017_1840_9
crossref_primary_10_1177_1358863X10378376
crossref_primary_10_1016_S1262_3636_07_80057_7
crossref_primary_10_9738_0020_8868_97_1_56
crossref_primary_10_3390_diagnostics11081407
crossref_primary_10_1590_1677_5449_20130092
crossref_primary_10_1016_j_jcct_2023_03_003
crossref_primary_10_1007_s00772_017_0326_z
crossref_primary_10_1161_CIRCULATIONAHA_107_763227
crossref_primary_10_1016_j_cpcardiol_2009_05_001
crossref_primary_10_1016_j_atherosclerosis_2020_09_026
crossref_primary_10_1016_j_jvs_2014_02_059
crossref_primary_10_1024_0301_1526_a000954
crossref_primary_10_1024_0301_1526_a000834
crossref_primary_10_1177_0003319712439092
crossref_primary_10_17352_2455_5452_000033
crossref_primary_10_1007_s00772_020_00689_2
crossref_primary_10_1161_HYPERTENSIONAHA_110_169169
crossref_primary_10_1016_j_jvs_2016_02_059
crossref_primary_10_1016_j_atherosclerosis_2006_02_017
crossref_primary_10_1024_0301_1526_a000835
crossref_primary_10_1016_j_cca_2019_04_061
crossref_primary_10_1007_s00059_018_4774_3
crossref_primary_10_1016_j_ejvs_2005_09_006
crossref_primary_10_1016_S1634_7358_23_47940_5
crossref_primary_10_1016_j_acvd_2009_05_004
crossref_primary_10_1016_j_cll_2006_06_008
crossref_primary_10_1016_j_knee_2020_09_019
crossref_primary_10_1007_s15027_014_0379_9
crossref_primary_10_1016_j_ejim_2008_09_013
crossref_primary_10_1177_0260106018817190
crossref_primary_10_1111_1753_0407_12873
crossref_primary_10_1097_RLI_0b013e3182183a77
crossref_primary_10_1024_0301_1526_a000808
crossref_primary_10_1016_j_ejim_2011_02_001
crossref_primary_10_1177_1708538115592800
crossref_primary_10_1007_s00108_009_2366_2
crossref_primary_10_1016_j_acvfr_2010_12_011
crossref_primary_10_1007_s11606_010_1412_z
crossref_primary_10_1007_s00772_010_0863_1
crossref_primary_10_1038_hr_2011_53
crossref_primary_10_1016_j_jacc_2011_08_023
crossref_primary_10_1080_13645706_2016_1190379
crossref_primary_10_1007_s12013_014_0043_0
crossref_primary_10_33546_bnj_742
crossref_primary_10_1024_0301_1526_a000810
crossref_primary_10_1016_j_cger_2019_07_009
crossref_primary_10_1186_1532_429X_15_14
crossref_primary_10_1371_journal_pone_0268201
crossref_primary_10_1186_s12245_022_00411_x
crossref_primary_10_1002_ccd_21238
crossref_primary_10_4174_astr_2016_90_4_218
crossref_primary_10_1007_s00772_010_0787_9
crossref_primary_10_1016_j_avsg_2010_03_015
crossref_primary_10_1093_qjmed_hcn140
crossref_primary_10_1111_j_1524_4733_2006_00079_x
crossref_primary_10_1007_s12170_011_0185_1
crossref_primary_10_3390_jcm12010097
crossref_primary_10_1016_S0214_9168_08_72576_2
crossref_primary_10_1177_1358863X20967091
crossref_primary_10_1583_05_1752_1
crossref_primary_10_1016_S0003_3170_07_75049_6
crossref_primary_10_1038_nrcardio_2011_66
crossref_primary_10_1007_s10554_021_02361_6
crossref_primary_10_1007_s00772_024_01136_2
crossref_primary_10_1080_00365513_2018_1497803
crossref_primary_10_1177_1755738015592043
crossref_primary_10_1038_s41598_021_84285_8
crossref_primary_10_1517_14728214_11_1_75
crossref_primary_10_1007_s15027_012_0328_4
crossref_primary_10_1016_j_ejvs_2005_01_001
crossref_primary_10_1016_j_pcd_2012_02_004
crossref_primary_10_1177_1534734607302238
crossref_primary_10_1371_journal_pone_0125032
crossref_primary_10_1016_j_jss_2020_03_030
crossref_primary_10_4093_dmj_2011_35_5_543
crossref_primary_10_1002_jmri_24463
crossref_primary_10_1016_j_jvs_2007_07_047
crossref_primary_10_1177_17085381221127051
crossref_primary_10_1016_j_atherosclerosis_2005_02_021
crossref_primary_10_1016_j_atherosclerosis_2014_08_032
crossref_primary_10_1016_j_ejvs_2006_03_007
crossref_primary_10_1024_0301_1526_a000969
crossref_primary_10_1111_j_1747_4949_2008_00220_x
crossref_primary_10_1007_s11789_008_0046_8
crossref_primary_10_1024_0301_1526_a000728
crossref_primary_10_1007_s00108_009_2364_4
crossref_primary_10_1016_j_jvs_2012_10_115
crossref_primary_10_1016_S0828_282X_09_70021_2
crossref_primary_10_1007_s00482_007_0556_1
crossref_primary_10_1007_s00772_020_00740_2
crossref_primary_10_1016_j_avsg_2017_12_007
crossref_primary_10_1016_j_atherosclerosis_2004_09_003
crossref_primary_10_1016_j_jvs_2006_04_002
crossref_primary_10_29333_ejgm_12278
crossref_primary_10_1016_j_amjcard_2020_12_091
crossref_primary_10_5758_vsi_210072
crossref_primary_10_1080_14017430510035844
crossref_primary_10_1016_S0398_0499_04_96769_8
crossref_primary_10_1007_s00772_008_0595_7
crossref_primary_10_1016_j_jvs_2022_04_048
crossref_primary_10_33678_cor_2010_117
crossref_primary_10_1016_j_jvs_2018_05_225
crossref_primary_10_1016_j_ejvs_2006_04_029
crossref_primary_10_1016_j_ejvs_2014_08_025
crossref_primary_10_1016_j_jvs_2019_08_271
crossref_primary_10_2337_dc14_2900
crossref_primary_10_1007_s00104_004_0982_x
crossref_primary_10_1007_s00132_009_1501_z
crossref_primary_10_3390_ijms242417439
crossref_primary_10_1177_0003319708322923
crossref_primary_10_1016_j_jvs_2006_05_016
crossref_primary_10_1007_s11428_017_0283_x
crossref_primary_10_1016_j_avsg_2018_05_070
crossref_primary_10_1186_1471_2261_11_59
crossref_primary_10_1111_j_1468_1331_2009_02874_x
crossref_primary_10_2174_1573399815666190531093238
crossref_primary_10_1089_jwh_2013_4653
crossref_primary_10_1157_13128016
crossref_primary_10_1016_j_jvs_2009_03_008
crossref_primary_10_4236_ss_2019_107026
crossref_primary_10_1016_j_avsg_2025_03_007
crossref_primary_10_1016_j_carrev_2012_05_003
crossref_primary_10_1007_s13340_017_0337_8
crossref_primary_10_1155_2019_8295054
crossref_primary_10_1024_0301_1526_a001085
crossref_primary_10_1016_j_atherosclerosis_2015_07_002
crossref_primary_10_1007_s00380_018_1210_9
crossref_primary_10_1016_j_ejim_2007_09_003
crossref_primary_10_1177_1538574415608269
crossref_primary_10_1016_S0104_4230_12_70248_8
crossref_primary_10_1111_j_1365_2796_2010_02322_x
crossref_primary_10_1016_j_semerg_2012_06_010
crossref_primary_10_3390_ijms160511131
crossref_primary_10_1016_j_avsg_2009_08_013
crossref_primary_10_1016_j_ejvs_2023_06_018
crossref_primary_10_1007_s00104_023_01821_0
crossref_primary_10_1007_s15034_016_0783_6
crossref_primary_10_1016_j_jclinepi_2009_10_009
crossref_primary_10_1177_1358863X07079823
crossref_primary_10_1016_j_jvs_2009_04_055
crossref_primary_10_1024_0301_1526_a001096
crossref_primary_10_1111_j_1445_2197_2006_03902_x
crossref_primary_10_1097_rmr_0b013e318159aaa2
crossref_primary_10_1177_17085381211053492
crossref_primary_10_1093_eurheartj_ehi644
crossref_primary_10_1186_1471_2261_11_39
crossref_primary_10_3238_PersKardio_2024_05_31_02
crossref_primary_10_1590_S0104_42302012000500011
crossref_primary_10_1177_154431671303700203
crossref_primary_10_18521_ktd_1439261
crossref_primary_10_1016_j_fmc_2015_02_021
crossref_primary_10_1016_S0003_3170_06_74959_8
crossref_primary_10_1016_j_ejim_2018_01_007
crossref_primary_10_1177_1358863X18807003
crossref_primary_10_1016_j_jacc_2015_12_049
crossref_primary_10_1024_0301_1526_a001068
crossref_primary_10_1007_s00117_016_0079_9
crossref_primary_10_1016_j_jvs_2010_07_010
crossref_primary_10_1002_ccd_23373
crossref_primary_10_1093_eurheartj_ehi636
crossref_primary_10_1016_j_acvfr_2011_01_033
crossref_primary_10_1177_0003319716638797
crossref_primary_10_1177_0003319710371614
crossref_primary_10_1038_s41598_018_32607_8
crossref_primary_10_1016_j_cjca_2010_12_029
crossref_primary_10_1007_s11789_007_0001_0
crossref_primary_10_1016_j_yasu_2008_03_014
crossref_primary_10_1007_s00772_020_00673_w
crossref_primary_10_1016_j_jvs_2019_03_071
crossref_primary_10_1024_0301_1526_a000901
crossref_primary_10_4103_mjhs_mjhs_151_22
crossref_primary_10_1007_s40520_018_1095_6
crossref_primary_10_1016_S0025_7753_09_71749_X
crossref_primary_10_1186_s12913_019_4477_3
crossref_primary_10_12687_phleb2368_4_2017
crossref_primary_10_1080_08941939_2019_1690600
crossref_primary_10_1097_HCO_0b013e328338c109
crossref_primary_10_5348_100062Z09ZB2021CR
crossref_primary_10_1016_j_jvs_2005_11_050
crossref_primary_10_1093_gerona_glz047
crossref_primary_10_1161_STROKEAHA_109_559740
crossref_primary_10_1177_0141076814557301
crossref_primary_10_1111_j_1365_2796_2005_01536_x
crossref_primary_10_5999_aps_2012_39_3_227
crossref_primary_10_1016_j_jvs_2011_09_001
crossref_primary_10_2310_6670_2006_00017
crossref_primary_10_1016_j_avsg_2013_01_020
crossref_primary_10_1111_j_1475_097X_2007_00720_x
crossref_primary_10_1016_j_jvs_2021_01_066
crossref_primary_10_1007_s00772_010_0831_9
crossref_primary_10_1186_1471_2482_8_22
crossref_primary_10_1007_s00059_020_04896_1
crossref_primary_10_1007_s00392_009_0754_1
crossref_primary_10_1186_1471_2261_11_4
crossref_primary_10_1016_j_apmr_2007_09_040
crossref_primary_10_3238_arztebl_m2022_0331
crossref_primary_10_18087_cardio_2021_3_n1498
crossref_primary_10_1016_j_foot_2012_08_008
crossref_primary_10_1016_j_jstrokecerebrovasdis_2011_04_006
crossref_primary_10_1159_000091087
crossref_primary_10_1159_000351720
crossref_primary_10_1002_ccd_24391
crossref_primary_10_1161_CIRCOUTCOMES_109_868505
crossref_primary_10_1053_j_semvascsurg_2022_05_003
crossref_primary_10_1080_00015458_2019_1586395
crossref_primary_10_1291_hypres_29_23
crossref_primary_10_1177_1534734620951528
crossref_primary_10_1016_j_cpcardiol_2014_05_003
crossref_primary_10_2217_ica_11_38
crossref_primary_10_1097_HJH_0b013e32832f4f54
crossref_primary_10_1177_1538574406296209
crossref_primary_10_1007_s00125_006_0587_7
crossref_primary_10_1038_s41598_023_48602_7
crossref_primary_10_1371_journal_pone_0244851
crossref_primary_10_3390_jcm13072141
crossref_primary_10_4137_CMC_S15230
crossref_primary_10_1177_1358863X08094800
crossref_primary_10_1016_j_jvs_2023_01_208
crossref_primary_10_1002_ccd_20906
crossref_primary_10_1016_j_ejvs_2014_12_027
crossref_primary_10_1016_j_ejvs_2023_08_067
crossref_primary_10_1007_s11883_011_0196_x
crossref_primary_10_1016_j_zefq_2009_06_005
crossref_primary_10_1007_s00772_013_1235_4
crossref_primary_10_1583_13_4275MR_1
crossref_primary_10_1097_MD_0000000000035285
crossref_primary_10_1148_radiol_2533081627
crossref_primary_10_1016_j_ahj_2005_01_008
crossref_primary_10_1155_2011_316496
crossref_primary_10_1002_gps_2351
crossref_primary_10_1007_s00772_024_01086_9
crossref_primary_10_1016_j_suc_2023_04_015
crossref_primary_10_1007_s11789_007_0007_7
crossref_primary_10_1016_j_ejvs_2023_01_026
crossref_primary_10_15829_1728_8800_2013_2_63_69
crossref_primary_10_1093_ejcts_ezad426
crossref_primary_10_1191_1358863x05vm635oa
crossref_primary_10_1007_s00772_023_00984_8
crossref_primary_10_4103_dmr_dmr_4_21
crossref_primary_10_1016_S1166_4568_09_45142_8
crossref_primary_10_1016_j_jss_2007_03_022
crossref_primary_10_1016_j_vasdi_2025_01_126
crossref_primary_10_1007_s00772_013_1269_7
crossref_primary_10_1583_08_2366_1
crossref_primary_10_1111_ijcp_13253
crossref_primary_10_1007_s11845_011_0779_0
crossref_primary_10_1161_CIRCULATIONAHA_107_726299
crossref_primary_10_1007_s00772_016_0234_7
crossref_primary_10_1007_s12262_016_1570_2
crossref_primary_10_1024_0301_1526_a001126
crossref_primary_10_1007_s15027_014_0360_7
crossref_primary_10_1016_j_arteri_2010_03_008
crossref_primary_10_1097_TGR_0b013e31828aa41a
crossref_primary_10_1157_13094431
crossref_primary_10_3390_medicina60010147
crossref_primary_10_1016_j_ahj_2024_06_010
crossref_primary_10_1016_S1078_5884_11_60011_7
crossref_primary_10_1111_j_1540_8159_2008_01100_x
crossref_primary_10_1177_15347346231212782
crossref_primary_10_1016_j_ccl_2010_08_003
crossref_primary_10_1186_s12912_020_00467_1
crossref_primary_10_1007_s40664_021_00452_8
crossref_primary_10_1016_j_ejvs_2023_08_005
crossref_primary_10_1177_1358863X11424312
crossref_primary_10_1016_S0003_3170_08_05001_3
crossref_primary_10_1161_CIRCULATIONAHA_105_605717
crossref_primary_10_1080_08037051_2017_1400903
crossref_primary_10_1016_j_jvs_2008_12_070
crossref_primary_10_1185_030079904X12780
crossref_primary_10_1007_s11789_007_0008_6
crossref_primary_10_1007_s40531_020_00040_0
crossref_primary_10_3390_jcm10050947
crossref_primary_10_1016_j_avsg_2010_09_013
crossref_primary_10_1016_j_ejvs_2023_01_002
crossref_primary_10_1111_ijcp_12148
crossref_primary_10_1007_s00772_013_1268_8
crossref_primary_10_1177_1358863X12445102
crossref_primary_10_1002_sim_9681
crossref_primary_10_3348_kjr_2010_11_4_441
crossref_primary_10_1007_s00423_018_1689_7
crossref_primary_10_3109_02813432_2012_675564
crossref_primary_10_1161_CIRCOUTCOMES_111_964379
crossref_primary_10_1177_0003319712448248
crossref_primary_10_3389_fcvm_2019_00008
crossref_primary_10_1161_CIRCULATIONAHA_109_865600
crossref_primary_10_1007_s11298_014_0006_1
crossref_primary_10_1159_000381254
crossref_primary_10_1002_14651858_CD003285_pub2
crossref_primary_10_1007_s00391_009_0051_7
crossref_primary_10_1177_1358863X221096704
crossref_primary_10_1097_01_rli_0000262581_52315_ef
crossref_primary_10_1007_s00482_009_0773_x
crossref_primary_10_1016_S1636_5410_23_47955_X
crossref_primary_10_1053_j_semvascsurg_2022_04_006
crossref_primary_10_1053_j_semvascsurg_2022_04_005
crossref_primary_10_1016_j_jmv_2015_03_001
crossref_primary_10_1007_s00392_010_0240_9
crossref_primary_10_3390_microorganisms10102065
crossref_primary_10_1016_j_jvs_2007_02_004
crossref_primary_10_1016_j_hlc_2018_04_292
crossref_primary_10_1016_j_ejim_2011_08_004
crossref_primary_10_1373_clinchem_2012_193656
crossref_primary_10_1016_j_jvs_2009_05_061
crossref_primary_10_1097_AJP_0b013e3182340c01
crossref_primary_10_1016_j_arteri_2010_04_001
crossref_primary_10_1177_153857440403800609
crossref_primary_10_1016_j_atherosclerosis_2005_07_022
crossref_primary_10_1016_j_ejvs_2005_06_008
crossref_primary_10_1007_s00772_013_1267_9
crossref_primary_10_1016_j_jvn_2013_09_002
crossref_primary_10_1024_0301_1526_a001041
crossref_primary_10_1161_HYPERTENSIONAHA_113_02094
crossref_primary_10_1016_j_jvs_2016_07_119
crossref_primary_10_3945_jn_114_204594
crossref_primary_10_1097_01_hjr_0000183912_05484_8f
crossref_primary_10_1007_s00330_008_1168_6
crossref_primary_10_1016_j_jvs_2008_05_072
crossref_primary_10_1161_CIRCULATIONAHA_105_607846
crossref_primary_10_1007_s00415_009_5017_6
crossref_primary_10_1185_03007990902860325
crossref_primary_10_1016_j_angio_2017_02_001
crossref_primary_10_3390_jcm10102048
crossref_primary_10_1016_j_avsg_2010_07_016
crossref_primary_10_1111_joic_12431
crossref_primary_10_1016_j_atherosclerosis_2009_11_016
crossref_primary_10_1007_s00108_017_0272_6
crossref_primary_10_1024_0301_1526_a001055
crossref_primary_10_1016_S0304_5412_09_73013_6
crossref_primary_10_7759_cureus_52019
crossref_primary_10_1007_s15006_014_3095_6
crossref_primary_10_1016_j_ejvs_2015_04_009
crossref_primary_10_1038_srep09937
crossref_primary_10_1016_j_ejvs_2009_04_013
crossref_primary_10_1016_j_ejvs_2021_05_016
crossref_primary_10_54912_jci_2023_0019
crossref_primary_10_1007_s00392_015_0834_3
crossref_primary_10_1111_iwj_13407
crossref_primary_10_1016_j_jvsv_2022_05_013
crossref_primary_10_1016_S1636_5410_13_65898_5
crossref_primary_10_1097_EDE_0000000000001630
crossref_primary_10_3389_fcvm_2022_1032755
crossref_primary_10_1016_j_ejim_2010_07_019
crossref_primary_10_1007_s00772_012_1010_y
crossref_primary_10_1007_s11428_014_1296_3
crossref_primary_10_1179_joc_2006_18_1_103
crossref_primary_10_1016_j_jvs_2010_05_105
crossref_primary_10_1177_20420188211000504
crossref_primary_10_1055_a_1535_2774
crossref_primary_10_1177_2047487313519344
crossref_primary_10_1016_j_atherosclerosis_2006_08_006
crossref_primary_10_1007_s15027_016_0749_6
crossref_primary_10_1186_1471_2261_6_33
crossref_primary_10_3400_avd_oa_12_00003
crossref_primary_10_1093_eurheartj_eht142
crossref_primary_10_1016_j_hipert_2011_12_001
crossref_primary_10_20996_1819_6446_2021_02_10
crossref_primary_10_1259_dmfr_20180432
crossref_primary_10_1097_01_RVI_0000137978_15352_C6
crossref_primary_10_1161_CIRCRESAHA_115_306884
Cites_doi 10.1161/01.ATV.18.2.185
10.1177/1358836X0100600204
10.1161/01.CIR.71.3.516
10.1093/ije/25.6.1172
10.1016/0021-9150(91)90014-T
10.1161/01.CIR.88.2.819
10.1093/ije/25.2.282
10.1001/jama.286.11.1317
10.1053/ejvs.1999.0843
10.1161/01.CIR.82.6.1925
10.1161/01.CIR.101.1.e16
10.1056/NEJM199202063260605
10.1016/S0140-6736(96)09457-3
10.1177/1358863X9600100112
10.1161/01.CIR.88.3.837
10.1001/archinte.159.4.387
10.1001/archinte.163.8.884
10.1002/bjs.1800560910
10.7326/0003-4819-136-12-200206180-00008
10.1001/archinte.163.8.877
10.1161/01.ATV.19.3.538
10.1016/S0140-6736(01)06351-6
ContentType Journal Article
Copyright 2003 Elsevier Ireland Ltd
2004 INIST-CNRS
Copyright_xml – notice: 2003 Elsevier Ireland Ltd
– notice: 2004 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/S0021-9150(03)00204-1
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 105
ExternalDocumentID 14709362
15383525
10_1016_S0021_9150_03_00204_1
S0021915003002041
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Europe
Germany
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OK1
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
Z5R
ZGI
ZXP
~G-
~KM
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
RIG
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFLBG
ID FETCH-LOGICAL-c511t-7d86b39cb10af03298300d910d9210eac48b562e758fee3735f79b693971c4af3
IEDL.DBID AIKHN
ISSN 0021-9150
IngestDate Fri Sep 05 13:10:22 EDT 2025
Wed Feb 19 02:33:13 EST 2025
Wed Apr 02 07:26:34 EDT 2025
Tue Jul 01 04:07:53 EDT 2025
Thu Apr 24 22:57:22 EDT 2025
Tue Feb 04 22:31:28 EST 2025
Tue Aug 26 20:39:46 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Prevalence
Ankle brachial index
Peripheral arterial disease
Cross-sectional study
Atherothrombosis
Primary care
Epidemiology
Doppler ultrasound study
Claudication
Systolic pressure
Diastolic pressure
Ankle brachial index: Primary care: Prevalence
Cardiovascular disease
Vascular disease
Arterial disease
Body mass index
Intermittent
Atherosclerosis
Cerebrovascular disease
Sonography
Human
Hypertension
Nervous system diseases
General practitioner
Morbidity
Cerebral disorder
Arteriopathy
Central nervous system disease
Risk factor
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-7d86b39cb10af03298300d910d9210eac48b562e758fee3735f79b693971c4af3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 14709362
PQID 80083684
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_80083684
pubmed_primary_14709362
pascalfrancis_primary_15383525
crossref_primary_10_1016_S0021_9150_03_00204_1
crossref_citationtrail_10_1016_S0021_9150_03_00204_1
elsevier_sciencedirect_doi_10_1016_S0021_9150_03_00204_1
elsevier_clinicalkey_doi_10_1016_S0021_9150_03_00204_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004
2004-1-00
2004-Jan
20040101
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Ireland
PublicationTitle Atherosclerosis
PublicationTitleAlternate Atherosclerosis
PublicationYear 2004
Publisher Elsevier Ireland Ltd
Elsevier
Publisher_xml – name: Elsevier Ireland Ltd
– name: Elsevier
References McDermott, Mehta, Greenland (BIB8) 1999; 159
Dormandy, Rutherford (BIB2) 2000; 31
Meijer, Hoes, Rutgers (BIB19) 1998; 18
Pittrow D, Wittchen HU, Kirch W. Hypertension and diabetes care among primary care doctors in Germany: results from an epidemiological cross-sectional study. In: Public Health in Europe. Kirch W, editor. Springer Verlag, Heidelberg, Germany, 2003.
Hirsch, Halverson, Treat-Jacobson (BIB27) 2001; 6
Kaiser, Kester, Stoffers (BIB13) 1999; 18
Criqui, Fronek, Klauber (BIB9) 1985; 71
Yao, Hobbs, Irvine (BIB14) 1969; 56
Smith, Shipley, Rose (BIB5) 1990; 82
Orchard, Strandness (BIB12) 1993; 88
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39.
Federal Statistical Office. Statistical Yearbook 2001 for the Federal Republic of Germany. Metzler-Poeschel, Stuttgart, 2001.
Halperin, Fuster (BIB29) 2003; 163
The getABI Study Group. The German Epidemiological Trial on Ankle Brachial Index (getABI): rationale, design and methods. VASA 2002;4:241–8.
Arbeitsgruppe Epidemiologische Methoden der Deutschen Arbeitsgemeinschaft Epidemiologie (DAE). Leitlinen und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). February 2000. Available: http://www.gmds.de/texte/onlinedocs/empfehlungen/empL.gep.langfassung.htm
Stoffers, Rinkens, Kester (BIB24) 1996; 25
Hirsch, Criqui, Treat-Jacobson (BIB26) 2001; 286
Rose (BIB18) 1962; 27
Criqui, Langer, Fronek (BIB3) 1992; 326
Newman, Shemanski, Manolio (BIB25) 1999; 19
Greenland, Abrams, Aurigemma (BIB11) 2000; 101
Criqui, Denenberg, Bird (BIB10) 1996; 1
Belch, Topol, Agnelli, Bertrand, Califf, Clement (BIB28) 2003; 163
Ouriel (BIB1) 2001; 358
Newman, Siscovick, Manolio (BIB7) 1993; 88
McKenna, Wolfson, Kuller (BIB4) 1991; 87
Olin JW. The clinical evaluation and office based detection of peripheral arterial disease. In: Hirsch AT, Olin FW, eds. An office-based approach to the diagnosis and treatment of peripheral arterial disease. Am J Med (Continuing Education Series) 1998:10–7.
Leng, Lee, Fowkes (BIB6) 1996; 25
McDermott, Greenland, Liu (BIB21) 2002; 136
Newman (10.1016/S0021-9150(03)00204-1_BIB25) 1999; 19
McKenna (10.1016/S0021-9150(03)00204-1_BIB4) 1991; 87
Greenland (10.1016/S0021-9150(03)00204-1_BIB11) 2000; 101
Belch (10.1016/S0021-9150(03)00204-1_BIB28) 2003; 163
Rose (10.1016/S0021-9150(03)00204-1_BIB18) 1962; 27
Orchard (10.1016/S0021-9150(03)00204-1_BIB12) 1993; 88
Criqui (10.1016/S0021-9150(03)00204-1_BIB9) 1985; 71
Smith (10.1016/S0021-9150(03)00204-1_BIB5) 1990; 82
Hirsch (10.1016/S0021-9150(03)00204-1_BIB26) 2001; 286
10.1016/S0021-9150(03)00204-1_BIB16
Kaiser (10.1016/S0021-9150(03)00204-1_BIB13) 1999; 18
10.1016/S0021-9150(03)00204-1_BIB15
McDermott (10.1016/S0021-9150(03)00204-1_BIB8) 1999; 159
10.1016/S0021-9150(03)00204-1_BIB17
Ouriel (10.1016/S0021-9150(03)00204-1_BIB1) 2001; 358
Criqui (10.1016/S0021-9150(03)00204-1_BIB3) 1992; 326
Criqui (10.1016/S0021-9150(03)00204-1_BIB10) 1996; 1
Yao (10.1016/S0021-9150(03)00204-1_BIB14) 1969; 56
10.1016/S0021-9150(03)00204-1_BIB20
Stoffers (10.1016/S0021-9150(03)00204-1_BIB24) 1996; 25
10.1016/S0021-9150(03)00204-1_BIB23
10.1016/S0021-9150(03)00204-1_BIB22
Newman (10.1016/S0021-9150(03)00204-1_BIB7) 1993; 88
Halperin (10.1016/S0021-9150(03)00204-1_BIB29) 2003; 163
Leng (10.1016/S0021-9150(03)00204-1_BIB6) 1996; 25
Dormandy (10.1016/S0021-9150(03)00204-1_BIB2) 2000; 31
Hirsch (10.1016/S0021-9150(03)00204-1_BIB27) 2001; 6
Meijer (10.1016/S0021-9150(03)00204-1_BIB19) 1998; 18
McDermott (10.1016/S0021-9150(03)00204-1_BIB21) 2002; 136
15186964 - Atherosclerosis. 2004 Jul;175(1):183-4; author reply 185-6
References_xml – volume: 88
  start-page: 837
  year: 1993
  end-page: 845
  ident: BIB7
  article-title: Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group
  publication-title: Circulation
– volume: 31
  start-page: S1
  year: 2000
  end-page: S296
  ident: BIB2
  article-title: Management of peripheral arterial disease (PAD). TASC Working Group
  publication-title: J. Vasc. Surg.
– volume: 56
  start-page: 676
  year: 1969
  end-page: 679
  ident: BIB14
  article-title: Ankle systolic pressure measurements in arterial disease affecting the lower extremities
  publication-title: Br. J. Surg.
– volume: 71
  start-page: 516
  year: 1985
  end-page: 522
  ident: BIB9
  article-title: The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from non-invasive testing in a defined population
  publication-title: Circulation
– volume: 163
  start-page: 877
  year: 2003
  end-page: 878
  ident: BIB29
  article-title: Meeting the challenge of peripheral arterial disease
  publication-title: Arch. Intern. Med.
– reference: Arbeitsgruppe Epidemiologische Methoden der Deutschen Arbeitsgemeinschaft Epidemiologie (DAE). Leitlinen und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). February 2000. Available: http://www.gmds.de/texte/onlinedocs/empfehlungen/empL.gep.langfassung.htm
– reference: The getABI Study Group. The German Epidemiological Trial on Ankle Brachial Index (getABI): rationale, design and methods. VASA 2002;4:241–8.
– volume: 18
  start-page: 185
  year: 1998
  end-page: 192
  ident: BIB19
  article-title: Peripheral arterial disease in the elderly: The Rotterdam Study
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– reference: Pittrow D, Wittchen HU, Kirch W. Hypertension and diabetes care among primary care doctors in Germany: results from an epidemiological cross-sectional study. In: Public Health in Europe. Kirch W, editor. Springer Verlag, Heidelberg, Germany, 2003.
– reference: Federal Statistical Office. Statistical Yearbook 2001 for the Federal Republic of Germany. Metzler-Poeschel, Stuttgart, 2001.
– volume: 286
  start-page: 1317
  year: 2001
  end-page: 1324
  ident: BIB26
  article-title: Peripheral arterial disease detection, awareness, and treatment in primary care
  publication-title: J. Am. Med. Assoc.
– reference: Olin JW. The clinical evaluation and office based detection of peripheral arterial disease. In: Hirsch AT, Olin FW, eds. An office-based approach to the diagnosis and treatment of peripheral arterial disease. Am J Med (Continuing Education Series) 1998:10–7.
– volume: 25
  start-page: 282
  year: 1996
  end-page: 290
  ident: BIB24
  article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease
  publication-title: Int. J. Epidemiol.
– volume: 18
  start-page: 25
  year: 1999
  end-page: 29
  ident: BIB13
  article-title: The influence of experience on the reproducibility of the ankle-brachial systolic pressure ratio in peripheral arterial occlusive disease
  publication-title: Eur. J. Vasc. Endovasc. Surg.
– volume: 6
  start-page: 87
  year: 2001
  end-page: 96
  ident: BIB27
  article-title: The Minnesota Regional Peripheral Arterial Disease Screening Program: towards a definition of community standards of care
  publication-title: Vasc. Med.
– volume: 87
  start-page: 119
  year: 1991
  end-page: 128
  ident: BIB4
  article-title: The ratio of ankle and arm arterial pressure as an independent predictor of mortality
  publication-title: Atherosclerosis
– volume: 101
  start-page: E16
  year: 2000
  end-page: E22
  ident: BIB11
  article-title: Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerotic burden: Writing Group III
  publication-title: Circulation
– volume: 88
  start-page: 819
  year: 1993
  end-page: 828
  ident: BIB12
  article-title: Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, 18–20 September, 1992 New Orleans, Louisiana
  publication-title: Circulation
– volume: 358
  start-page: 1257
  year: 2001
  end-page: 1264
  ident: BIB1
  article-title: Peripheral arterial disease
  publication-title: Lancet
– volume: 19
  start-page: 538
  year: 1999
  end-page: 545
  ident: BIB25
  article-title: Ankle–arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 25
  start-page: 1172
  year: 1996
  end-page: 1181
  ident: BIB6
  article-title: Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population
  publication-title: Int. J. Epidemiol.
– volume: 136
  start-page: 873
  year: 2002
  end-page: 883
  ident: BIB21
  article-title: The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study
  publication-title: Ann. Intern. Med.
– volume: 326
  start-page: 381
  year: 1992
  end-page: 386
  ident: BIB3
  article-title: Mortality over a period of 10 years in patients with peripheral arterial disease
  publication-title: N. Engl. J. Med.
– volume: 82
  start-page: 1925
  year: 1990
  end-page: 1931
  ident: BIB5
  article-title: Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study
  publication-title: Circulation
– volume: 159
  start-page: 387
  year: 1999
  end-page: 392
  ident: BIB8
  article-title: Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease
  publication-title: Arch. Intern. Med.
– volume: 163
  start-page: 884
  year: 2003
  end-page: 892
  ident: BIB28
  article-title: Critical issues in peripheral arterial disease detection and management: a call to action
  publication-title: Arch. Intern. Med.
– reference: CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39.
– volume: 1
  start-page: 65
  year: 1996
  end-page: 71
  ident: BIB10
  article-title: The correlation between symptoms and non- invasive test results in patients referred for peripheral arterial disease testing
  publication-title: Vasc. Med.
– volume: 27
  start-page: 645
  year: 1962
  end-page: 658
  ident: BIB18
  article-title: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
  publication-title: Bull. World Health Organ.
– volume: 18
  start-page: 185
  year: 1998
  ident: 10.1016/S0021-9150(03)00204-1_BIB19
  article-title: Peripheral arterial disease in the elderly: The Rotterdam Study
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.18.2.185
– volume: 6
  start-page: 87
  year: 2001
  ident: 10.1016/S0021-9150(03)00204-1_BIB27
  article-title: The Minnesota Regional Peripheral Arterial Disease Screening Program: towards a definition of community standards of care
  publication-title: Vasc. Med.
  doi: 10.1177/1358836X0100600204
– ident: 10.1016/S0021-9150(03)00204-1_BIB22
– volume: 71
  start-page: 516
  issue: 3
  year: 1985
  ident: 10.1016/S0021-9150(03)00204-1_BIB9
  article-title: The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from non-invasive testing in a defined population
  publication-title: Circulation
  doi: 10.1161/01.CIR.71.3.516
– volume: 25
  start-page: 1172
  year: 1996
  ident: 10.1016/S0021-9150(03)00204-1_BIB6
  article-title: Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/25.6.1172
– volume: 87
  start-page: 119
  year: 1991
  ident: 10.1016/S0021-9150(03)00204-1_BIB4
  article-title: The ratio of ankle and arm arterial pressure as an independent predictor of mortality
  publication-title: Atherosclerosis
  doi: 10.1016/0021-9150(91)90014-T
– volume: 88
  start-page: 819
  year: 1993
  ident: 10.1016/S0021-9150(03)00204-1_BIB12
  article-title: Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, 18–20 September, 1992 New Orleans, Louisiana
  publication-title: Circulation
  doi: 10.1161/01.CIR.88.2.819
– ident: 10.1016/S0021-9150(03)00204-1_BIB20
– volume: 27
  start-page: 645
  year: 1962
  ident: 10.1016/S0021-9150(03)00204-1_BIB18
  article-title: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
  publication-title: Bull. World Health Organ.
– volume: 25
  start-page: 282
  year: 1996
  ident: 10.1016/S0021-9150(03)00204-1_BIB24
  article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/25.2.282
– ident: 10.1016/S0021-9150(03)00204-1_BIB17
– volume: 31
  start-page: S1
  issue: 1 Pt. 2
  year: 2000
  ident: 10.1016/S0021-9150(03)00204-1_BIB2
  article-title: Management of peripheral arterial disease (PAD). TASC Working Group
  publication-title: J. Vasc. Surg.
– volume: 286
  start-page: 1317
  issue: 11
  year: 2001
  ident: 10.1016/S0021-9150(03)00204-1_BIB26
  article-title: Peripheral arterial disease detection, awareness, and treatment in primary care
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.286.11.1317
– volume: 18
  start-page: 25
  issue: 1
  year: 1999
  ident: 10.1016/S0021-9150(03)00204-1_BIB13
  article-title: The influence of experience on the reproducibility of the ankle-brachial systolic pressure ratio in peripheral arterial occlusive disease
  publication-title: Eur. J. Vasc. Endovasc. Surg.
  doi: 10.1053/ejvs.1999.0843
– volume: 82
  start-page: 1925
  year: 1990
  ident: 10.1016/S0021-9150(03)00204-1_BIB5
  article-title: Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study
  publication-title: Circulation
  doi: 10.1161/01.CIR.82.6.1925
– ident: 10.1016/S0021-9150(03)00204-1_BIB23
– volume: 101
  start-page: E16
  issue: 1
  year: 2000
  ident: 10.1016/S0021-9150(03)00204-1_BIB11
  article-title: Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerotic burden: Writing Group III
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.1.e16
– volume: 326
  start-page: 381
  year: 1992
  ident: 10.1016/S0021-9150(03)00204-1_BIB3
  article-title: Mortality over a period of 10 years in patients with peripheral arterial disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199202063260605
– ident: 10.1016/S0021-9150(03)00204-1_BIB15
  doi: 10.1016/S0140-6736(96)09457-3
– volume: 1
  start-page: 65
  issue: 1
  year: 1996
  ident: 10.1016/S0021-9150(03)00204-1_BIB10
  article-title: The correlation between symptoms and non- invasive test results in patients referred for peripheral arterial disease testing
  publication-title: Vasc. Med.
  doi: 10.1177/1358863X9600100112
– volume: 88
  start-page: 837
  issue: 3
  year: 1993
  ident: 10.1016/S0021-9150(03)00204-1_BIB7
  article-title: Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group
  publication-title: Circulation
  doi: 10.1161/01.CIR.88.3.837
– volume: 159
  start-page: 387
  issue: 4
  year: 1999
  ident: 10.1016/S0021-9150(03)00204-1_BIB8
  article-title: Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease
  publication-title: Arch. Intern. Med.
  doi: 10.1001/archinte.159.4.387
– volume: 163
  start-page: 884
  year: 2003
  ident: 10.1016/S0021-9150(03)00204-1_BIB28
  article-title: Critical issues in peripheral arterial disease detection and management: a call to action
  publication-title: Arch. Intern. Med.
  doi: 10.1001/archinte.163.8.884
– volume: 56
  start-page: 676
  issue: 9
  year: 1969
  ident: 10.1016/S0021-9150(03)00204-1_BIB14
  article-title: Ankle systolic pressure measurements in arterial disease affecting the lower extremities
  publication-title: Br. J. Surg.
  doi: 10.1002/bjs.1800560910
– volume: 136
  start-page: 873
  issue: 12
  year: 2002
  ident: 10.1016/S0021-9150(03)00204-1_BIB21
  article-title: The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-136-12-200206180-00008
– ident: 10.1016/S0021-9150(03)00204-1_BIB16
– volume: 163
  start-page: 877
  year: 2003
  ident: 10.1016/S0021-9150(03)00204-1_BIB29
  article-title: Meeting the challenge of peripheral arterial disease
  publication-title: Arch. Intern. Med.
  doi: 10.1001/archinte.163.8.877
– volume: 19
  start-page: 538
  issue: 3
  year: 1999
  ident: 10.1016/S0021-9150(03)00204-1_BIB25
  article-title: Ankle–arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.19.3.538
– volume: 358
  start-page: 1257
  year: 2001
  ident: 10.1016/S0021-9150(03)00204-1_BIB1
  article-title: Peripheral arterial disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(01)06351-6
– reference: 15186964 - Atherosclerosis. 2004 Jul;175(1):183-4; author reply 185-6
SSID ssj0004718
Score 2.3654926
Snippet We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise....
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 95
SubjectTerms Aged
Aged, 80 and over
Ankle - blood supply
Ankle brachial index
Arteriosclerosis - epidemiology
Atherosclerosis (general aspects, experimental research)
Atherothrombosis
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Comorbidity
Cross-Sectional Studies
Cross-sectional study
Diabetic Angiopathies - epidemiology
Epidemiology
Female
Germany - epidemiology
Humans
Male
Medical sciences
Peripheral arterial disease
Peripheral Vascular Diseases - diagnostic imaging
Peripheral Vascular Diseases - epidemiology
Prevalence
Primary care
Primary Health Care
Risk Factors
Ultrasonography
Title High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0021915003002041
https://dx.doi.org/10.1016/S0021-9150(03)00204-1
https://www.ncbi.nlm.nih.gov/pubmed/14709362
https://www.proquest.com/docview/80083684
Volume 172
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB3RRaoqVajfXWi3PnCgh0CcOE7MDaGihQpOReJm2YktrUST1e5y5bcz4zhEHBBVLzlYGsv2jGee45lngH0v6FFuopz1jUtEjh9Vc594w5uqsBaDDv3Qv7yS82txcVPcbMHpUAtDaZXR9_c-PXjr2HIUV_NouVhQjS_uNsQzaKZU4YlHoO0Mo301ge2T89_zq7E8suS9Q6ZsBBQYC3n6TkLjQZr_DP0k_LkQ9XZp1rhwvn_x4nlIGkLT2TvYiZiSnfTDfg9brv0Ary_jrflH2FAyB1uuiNmbJsg6z4jgODAK3LKQ1YlmyOJlDTNtw-ou-dut7KJBlM4WLZO4A7GLQE3BKF2MRUbW9TEL00jWIamLBhIoaz_B9dmvP6fzJL62kNQIujZJ2VTS5qq2PDU-zTNV4bo2iCYahcdC9M-isgiWHB4wvHN5mRe-VFYqBDS8Fsbnn2HSdq37CozLrCmKwpisdMJ5qbxXsjC1KosyS206BTEssK4jFTm9iHGrx5wz1Ismveg010Evmk_h8FEsTvglATloTw-FpugaNUaLlwSrR8En1vgvorMnZjKOFEMLcc9O4cdgNxq3Mt3PmNZ1d2tdER6WlZjCl96cRllRpgqhxu7_j2sP3vRJR_T36BtMNqs79x3x1MbO4NXhPZ_FXfMAZBUVmw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB6hIu0irdC-YAu74AMH9hBIGseJ94aqRWWhPYHEzbITW6oESdWW_8-M4xD1gEB7ycHSWH6MZz7HM98AnDhORbmJctZVNuIpfmSZuMjppCoyY9Dp0A_96UxM7vi_--x-C8ZdLgyFVQbb39p0b61Dy3lYzfPFfE45vnjaEM-gmlKGJ16BtjkVtR7A9sXV9WTWp0fmSWuQKRoBBfpEnrYT33gap799P1Hymov6tNArXDjXVrx4HZJ613T5GXYDpmQX7bC_wJatv8KHaXg1_wZrCuZgiyUxe9MEWeMYERx7RoEH5qM6UQ1ZeKxhuq5Y2USPzdLMK0TpbF4zgScQu_DUFIzCxVhgZF39YX4a0coHddFAPGXtd7i7_Hs7nkSh2kJUIuhaR3lVCJPK0iSxdnE6kgWua4VoopJ4LUT7zAuDYMniBcNZm-Zp5nJphERAk5Rcu3QPBnVT2x_AEjGqsizTepRbbp2QzkmR6VLmWT6KTTwE3i2wKgMVOVXEeFB9zBnui6J9UXGq_L6oZAhnL2Jhwm8JiG73VJdoiqZRobd4S7B4EdzQxveIHm2oST9SdC3EPTuE405vFB5lep_RtW2eVqogPCwKPoT9Vp16WZ7HEqHGwf-P6xg-Tm6nN-rmanZ9CDttABL9SfoJg_Xyyf5CbLU2R-HsPAPrTxeB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+prevalence+of+peripheral+arterial+disease+and+co-morbidity+in+6880+primary+care+patients%3A+cross-sectional+study&rft.jtitle=Atherosclerosis&rft.au=DIEHM%2C+Curt&rft.au=SCHUSTER%2C+Alexander&rft.au=ALLENBERG%2C+Jens+R&rft.au=DARIUS%2C+Harald&rft.date=2004&rft.pub=Elsevier&rft.issn=0021-9150&rft.volume=172&rft.issue=1&rft.spage=95&rft.epage=105&rft_id=info:doi/10.1016%2FS0021-9150%2803%2900204-1&rft.externalDBID=n%2Fa&rft.externalDocID=15383525
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9150&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9150&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9150&client=summon